Agentix (AGTX) Retained Earnings (2014 - 2026)
Agentix's (AGTX) quarterly Retained Earnings came in at $29755.0 in Q1 2026, down 15.9% YoY from $35381.0 in Q1 2025, and down 40.68% on a QoQ basis from $50156.0 in Q4 2025.
Agentix (AGTX) Retained Earnings (2014 - 2026) Analysis & Trends
Agentix (AGTX) has 13 years of Retained Earnings data on file, last reported at $29755.0 in Q1 2026.
- Quarterly Retained Earnings fell 15.9% year-over-year to $29755.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29755.0 (down 15.9% YoY) and the FY2026 annual result came in at $29755.0, down 15.9% from the prior year.
- Retained Earnings fell to $29755.0 in Q1 2026, from $50156.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $3.3 million in Q2 2025 to a low of -$6.9 million in Q3 2025.
- A 5-year average of -$1.3 million and a median of $29755.0 in 2026 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 323.64% — and 2025, when it plunged 29939.72%.
- Tracing AGTX's Retained Earnings over 5 years: stood at -$4.9 million in 2022, then soared by 161.27% to $3.0 million in 2023, then tumbled by 309.52% to -$6.3 million in 2024, then surged by 100.79% to $50156.0 in 2025, then sank by 40.68% to $29755.0 in 2026.
- The last three Retained Earnings figures came in at $29755.0 (Q1 2026), $50156.0 (Q4 2025), and -$6.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 4.38 Bn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | -7.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.12 Mn |
| Mar 31, 2026 | 29,755.00 |
| Dec 31, 2025 | 50,156.00 |
| Sep 30, 2025 | -6.85 Mn |
| Jun 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | 35,381.00 |
| Dec 31, 2024 | -6.34 Mn |
| Sep 30, 2024 | -22,808.00 |
| Jun 30, 2024 | -6.11 Mn |
| Mar 31, 2024 | -5.95 Mn |
| Dec 31, 2023 | 3.03 Mn |
| Sep 30, 2023 | 3.03 Mn |
| Jun 30, 2023 | -5.78 Mn |
| Mar 31, 2023 | 3.03 Mn |
| Dec 31, 2022 | -4.94 Mn |
| Sep 30, 2022 | -4.58 Mn |
| Jun 30, 2022 | 2.88 Mn |
| Feb 28, 2022 | 2.88 Mn |
| Nov 30, 2021 | -1.87 Mn |
| Aug 31, 2021 | -1.70 Mn |